Chemotherapy‐related hemolytic‐uremic syndrome after the treatment of head and neck cancer. A case report

William J. Gradishar*, Everett E. Vokes, Kai Ni, William R. Panje

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

A 62‐year‐old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy‐related hemolytic‐uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate. Though the syndrome was suspected early, attempts at reversing the hematologic and renal abnormalities were unsuccessful. At postmortem examination, the characteristic microvascular lesions of the hemolyticuremic syndrome were found in the kidneys.

Original languageEnglish (US)
Pages (from-to)1914-1918
Number of pages5
Journalcancer
Volume66
Issue number9
DOIs
StatePublished - Nov 1 1990

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Chemotherapy‐related hemolytic‐uremic syndrome after the treatment of head and neck cancer. A case report'. Together they form a unique fingerprint.

Cite this